QQ客服 官方微博 反馈留言

	Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.
	Wang, Zhongtai; Zhang, Hui*; Zhou, Chunhua; Long, Xiaoyan; Guan, Rui; Yang, Nong*; Zhang, Yongchang
刊名	Cancer Medicine
	2019
卷号	8期号:4页码:1434-1441
关键词	chemotherapy different administration non-small cell lung cancer real-world study recombinant human-endostatin
ISSN号	2045-7634
DOI	10.1002/cam4.2014
URL标识	查看原文
WOS记录号	WOS:000477027100011
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5683439
专题	南华大学
作者单位	1.[Zhang, Hui 2.Zhou, Chunhua 3.Long, Xiaoyan 4.Guan, Rui 5.Yang, Nong 6.Wang, Zhongtai 7.Zhang, Yongchang] Cent S Univ, Dept Med Oncol, Lung Canc & Gastrointestinal Unit, Hunan Canc Hosp,Affiliated Canc Hosp,Xiangya Sch, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Wang, Zhongtai,Zhang, Hui*,Zhou, Chunhua,et al. Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.[J]. Cancer Medicine,2019,8(4):1434-1441.
APA	Wang, Zhongtai.,Zhang, Hui*.,Zhou, Chunhua.,Long, Xiaoyan.,Guan, Rui.,...&Zhang, Yongchang.(2019).Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer..Cancer Medicine,8(4),1434-1441.
MLA	Wang, Zhongtai,et al."Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.".Cancer Medicine 8.4(2019):1434-1441.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。